Immunostimulatory Polymers as Adjuvants, Immunotherapies, and Delivery Systems

Adam M. Weiss; Samir Hossainy; Stuart J. Rowan; Jeffrey A. Hubbell; Aaron P. Esser-Kahn

doi:10.1021/acs.macromol.2c00854

journal article Open Access Aug 04, 2022

Immunostimulatory Polymers as Adjuvants, Immunotherapies, and Delivery Systems

Adam M. Weiss

Samir Hossainy Stuart J. Rowan

Jeffrey A. Hubbell

Aaron P. Esser-Kahn

Macromolecules Vol. 55 No. 16 pp. 6913-6937 · American Chemical Society (ACS)

View at Publisher Save 10.1021/acs.macromol.2c00854

Topics

No keywords indexed for this article. Browse by subject →

References

248

[1]

Synthetic Nanoparticles for Vaccines and Immunotherapy

Darrell J. Irvine, Melissa C. Hanson, Kavya Rakhra et al.

Chemical Reviews 10.1021/acs.chemrev.5b00109

[2]

10.1021/acs.chemrev.5b00589

[3]

10.1039/c3py01376f

[4]

10.1016/j.addr.2020.06.021

[5]

Natural and synthetic carbohydrate-based vaccine adjuvants and their mechanisms of action

Carlo Pifferi, Roberto Fuentes, Alberto Fernández-Tejada

Nature Reviews Chemistry 10.1038/s41570-020-00244-3

[6]

10.1016/j.tibtech.2018.10.004

[7]

10.1038/nbt.3371

[8]

10.1021/acs.accounts.8b00292

[9]

10.1016/j.bpj.2019.07.026

[10]

10.1023/a:1016084508097

[11]

10.1084/jem.50.4.533

[12]

10.1084/jem.54.3.437

[13]

10.1080/00222337008074366

[14]

10.1002/jps.2600550114

[15]

10.1073/pnas.86.18.6982

[16]

10.1021/ar00034a004

[17]

10.1016/s0169-409x(02)00228-4

[18]

10.1016/j.jconrel.2003.12.021

[19]

10.1016/s0169-409x(01)00245-9

[20]

Emerging applications of stimuli-responsive polymer materials

Martien A. Cohen Stuart, Wilhelm T. S. Huck, Jan Genzer et al.

Nature Materials 10.1038/nmat2614

[21]

Reversible-deactivation radical polymerization (Controlled/living radical polymerization): From discovery to materials design and applications

Nathaniel Corrigan, Kenward Jung, Graeme Moad et al.

Progress in Polymer Science 10.1016/j.progpolymsci.2020.101311

[22]

10.1016/j.biomaterials.2020.120597

[23]

10.1039/c2cs35094g

[24]

10.1021/acs.chemrev.8b00006

[25]

Principles of nanoparticle design for overcoming biological barriers to drug delivery

Elvin Blanco, Haifa Shen, Mauro Ferrari

Nature Biotechnology 10.1038/nbt.3330

[26]

Murphy K. (2012)

[27]

10.1038/ni.2039

[28]

Vaccine Adjuvants: Putting Innate Immunity to Work

Robert L. Coffman, Alan Sher, Robert A. Seder

Immunity 10.1016/j.immuni.2010.10.002

[29]

Control of adaptive immunity by the innate immune system

Akiko Iwasaki, Ruslan Medzhitov

Nature Immunology 10.1038/ni.3123

[30]

Harnessing innate immunity in cancer therapy

Olivier Demaria, Stéphanie Cornen, Marc Daëron et al.

Nature 10.1038/s41586-019-1593-5

[31]

10.1146/annurev.immunol.26.021607.090248

[32]

10.1007/s40264-015-0350-4

[33]

Emerging concepts in the science of vaccine adjuvants

Bali Pulendran, Prabhu S. Arunachalam, Derek T. O’Hagan

Nature Reviews Drug Discovery 10.1038/s41573-021-00163-y

[34]

10.1016/j.vaccine.2011.09.061

[35]

10.1038/nm.2306

[36]

Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older

Anthony L. Cunningham, Himal Lal, Martina Kovac et al.

New England Journal of Medicine 10.1056/nejmoa1603800

[37]

Adjuvant system AS01: helping to overcome the challenges of modern vaccines

Arnaud M. Didierlaurent, Béatrice Laupèze, Alberta Di Pasquale et al.

Expert Review of Vaccines 10.1080/14760584.2016.1213632

[38]

10.1016/s0140-6736(07)60946-5

[39]

10.1016/j.vaccine.2017.12.038

[40]

10.1016/j.biomaterials.2019.119633

[41]

10.1038/nrd3012

[42]

10.1016/j.addr.2020.04.006

[43]

10.3389/fimmu.2013.00248

[44]

10.1093/glycob/cwq193

[45]

10.1038/nri2056

[46]

10.1038/nri2536

[47]

Putting endotoxin to work for us: Monophosphoryl lipid A as a safe and effective vaccine adjuvant

C. R. Casella, T. C. Mitchell

Experientia 10.1007/s00018-008-8228-6

[48]

10.1038/s41577-018-0004-8

[49]

10.1093/glycob/12.4.43r

[50]

10.1002/eji.1830270942

Showing 50 of 248 references

Metrics

73

Citations

248

References

Details

Published: Aug 04, 2022
Vol/Issue: 55(16)
Pages: 6913-6937
License: View

Authors

A

Adam M. Weiss

Pritzker School of Molecular Engineering, University of Chicago 5640 S. Ellis Ave., Chicago, Illinois 60637, United States; Department of Chemistry, University of Chicago 5735 S Ellis Ave., Chicago, Illinois 60637, United States

S

Samir Hossainy

Pritzker School of Molecular Engineering, University of Chicago 5640 S. Ellis Ave., Chicago, Illinois 60637, United States

S

Stuart J. Rowan

Pritzker School of Molecular Engineering, University of Chicago 5640 S. Ellis Ave., Chicago, Illinois 60637, United States; Department of Chemistry, University of Chicago 5735 S Ellis Ave., Chicago, Illinois 60637, United States

J

Jeffrey A. Hubbell

Pritzker School of Molecular Engineering, University of Chicago 5640 S. Ellis Ave., Chicago, Illinois 60637, United States

A

Aaron P. Esser-Kahn

Pritzker School of Molecular Engineering, University of Chicago 5640 S. Ellis Ave., Chicago, Illinois 60637, United States

Funding

National Cancer Institute Award: R01 CA219304

National Institute of General Medical Sciences Award: T32 GM008720

National Institute of Allergy and Infectious Diseases Award: U01AI124286

National Science Foundation Award: 1743475

Defense Threat Reduction Agency Award: 1-18-1-0052

AbbVie-UChicago Program in Immuno-oncology

Cite This Article

Adam M. Weiss, Samir Hossainy, Stuart J. Rowan, et al. (2022). Immunostimulatory Polymers as Adjuvants, Immunotherapies, and Delivery Systems. Macromolecules, 55(16), 6913-6937. https://doi.org/10.1021/acs.macromol.2c00854

Immunostimulatory Polymers as Adjuvants, Immunotherapies, and Delivery Systems

You May Also Like